Trials / Recruiting
RecruitingNCT06003036
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine
Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Deepak K. Sarpal, M.D. · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic resonance imaging (MRI), participants will undergo a session of iTBS +MRI and session of sham delivery + MRI. The order for these sessions will be blinded and randomized. The investigators predict that accelerated iTBS will enhance neurocognition relative to sham delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sham stimulation | sham delivery of transcranial magnetic stimulation |
| DEVICE | transcranial magnetic stimulation | accelerated intermittent theta burst stimulation |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2026-02-28
- Completion
- 2026-07-01
- First posted
- 2023-08-21
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06003036. Inclusion in this directory is not an endorsement.